To highlight Rare Disease Day on 29th February, French cosmetics and pharmaceutical business Pierre Fabre Laboratories, shared more on its work to address rare childhood diseases, which it said affects more than 200 million children worldwide.
Daily protection against the entire UV spectrum, including ultra-long UVA, can help slow signs of photoageing across all skin phototypes and ancestry, according to global clinical studies from beauty major L’Oréal.
Colgate-Palmolive has partnered with research organisation Verily Life Sciences to conduct a two-year clinical trial investigating the link between oral health and systemic human health conditions, specifically cardiovascular disease and Type II diabetes.
![L'Oréal recently completed a one-year long study in Brazil showing daily standard UV protection is critical in slowing signs of photoageing and had also proven the power of full-spectrum UVA protection across different phototypes in Brazil and East Asia [Getty Images]](/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/cosmetics/cosmeticsdesign-europe.com/article/2022/11/04/l-oreal-uv-protection-photoageing-clinical-studies-shows-ultra-long-uva-protection-important/15914339-1-eng-GB/L-Oreal-UV-protection-photoageing-clinical-studies-shows-ultra-long-UVA-protection-important.jpg)
![The two-year clinical study will be conducted in partnership with Verily Life Sciences to look at the link between oral care and the systemic health conditions cardiovascular disease and Type II diabetes [Getty Images]](/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/cosmetics/cosmeticsdesign-europe.com/headlines/formulation-science/colgate-palmolive-starts-oral-health-clinical-study-with-verily-life-sciences-investigating-systemic-conditions/12745564-1-eng-GB/Colgate-Palmolive-starts-oral-health-clinical-study-with-Verily-Life-Sciences-investigating-systemic-conditions.jpg)
